GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (XCNQ:CXXI) » Definitions » FCF Margin %

C21 Investments (XCNQ:CXXI) FCF Margin % : 11.11% (As of Dec. 2024)


View and export this data going back to 1987. Start your Free Trial

What is C21 Investments FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. C21 Investments's Free Cash Flow for the three months ended in Dec. 2024 was C$1.25 Mil. C21 Investments's Revenue for the three months ended in Dec. 2024 was C$11.27 Mil. Therefore, C21 Investments's FCF Margin % for the quarter that ended in Dec. 2024 was 11.11%.

As of today, C21 Investments's current FCF Yield % is -12.07%.

The historical rank and industry rank for C21 Investments's FCF Margin % or its related term are showing as below:

XCNQ:CXXI' s FCF Margin % Range Over the Past 10 Years
Min: -447.83   Med: 13.26   Max: 25.39
Current: -8.88


During the past 13 years, the highest FCF Margin % of C21 Investments was 25.39%. The lowest was -447.83%. And the median was 13.26%.

XCNQ:CXXI's FCF Margin % is ranked worse than
71.57% of 985 companies
in the Drug Manufacturers industry
Industry Median: 0.86 vs XCNQ:CXXI: -8.88


C21 Investments FCF Margin % Historical Data

The historical data trend for C21 Investments's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C21 Investments FCF Margin % Chart

C21 Investments Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -447.83 13.26 25.39 12.96 18.89

C21 Investments Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Jun24 Sep24 Dec24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.25 7.76 -45.82 -12.58 11.11

Competitive Comparison of C21 Investments's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C21 Investments's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's FCF Margin % distribution charts can be found below:

* The bar in red indicates where C21 Investments's FCF Margin % falls into.


;
;

C21 Investments FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

C21 Investments's FCF Margin for the fiscal year that ended in Jan. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Jan. 2023 )/Revenue (A: Jan. 2023 )
=7.326/38.773
=18.89 %

C21 Investments's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=1.252/11.267
=11.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C21 Investments FCF Margin % Related Terms

Thank you for viewing the detailed overview of C21 Investments's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


C21 Investments Business Description

Traded in Other Exchanges
Address
601 West Cordova Street, Suite 170, Vancouver, BC, CAN, V6B 1G1
C21 Investments Inc is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The Company owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles.
Executives
Todd Andrew Harrison Director
Bruce Macdonald Director
Sky Pinnick Director
Leonard Werden Director
Michael Starrett Kidd Director, Senior Officer

C21 Investments Headlines

No Headlines